Adenocarcinoma
|
0.400 |
AlteredExpression
|
group |
BEFREE |
ERα and ERβ expression profiling in paired normal oesophageal mucosa and tumour tissues (n = 34; adenocarcinoma n = 28; squamous cell carcinoma n = 6) was performed using quantitative reverse transcription polymerase chain reaction (qRT-PCR).
|
29390981 |
2018 |
Adenocarcinoma
|
0.400 |
Biomarker
|
group |
BEFREE |
The objective was to characterize and associate the receptor reactivities of fibroblastic growth factor (FGF)-2, FGF-7, FGF-8, epidermal growth factor (EGF), α-actin and vimentin in relation to the androgen receptor (AR), α and β estrogen receptors (ERα and ERβ), and prolactin receptor in the prostate of elderly men showing low- and high-grade adenocarcinoma.
|
23362007 |
2013 |
Adenocarcinoma
|
0.400 |
AlteredExpression
|
group |
BEFREE |
ERβ was most frequently expressed in Stage I ADCAs, especially in male subjects.
|
22583357 |
2012 |
Adenocarcinoma
|
0.400 |
Biomarker
|
group |
BEFREE |
Human estrogen receptor alpha is highly homologous to estrogen receptor beta and consequently, antibodies used to detect estrogen receptor alpha in breast carcinomas may detect estrogen receptor beta in pulmonary adenocarcinomas.
|
19875957 |
2010 |
Adenocarcinoma
|
0.400 |
AlteredExpression
|
group |
LHGDN |
Using a 2-level (high/low) score system, estrogen receptor beta expression was high in most (75%) adenocarcinomas and turned out to be strongly related to the histologic subtypes.
|
18620727 |
2008 |
Adenocarcinoma
|
0.400 |
Biomarker
|
group |
CTD_human |
Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma.
|
17639508 |
2007 |
Adenocarcinoma
|
0.400 |
AlteredExpression
|
group |
BEFREE |
Altered expression of ERalpha and ERbeta in tumors compared with corresponding normal gastric tissues was more common in poorly differentiated adenocarcinomas and related to malignant properties, such as lymph node metastasis.
|
17046193 |
2007 |
Adenocarcinoma
|
0.400 |
AlteredExpression
|
group |
LHGDN |
Altered expression of ERalpha and ERbeta in tumors compared with corresponding normal gastric tissues was more common in poorly differentiated adenocarcinomas and related to malignant properties, such as lymph node metastasis.
|
17046193 |
2007 |
Adenocarcinoma
|
0.400 |
Biomarker
|
group |
BEFREE |
Immunohistochemical evaluation of androgen receptor (AR), estrogen receptor-alpha (ER-alpha), estrogen receptor-beta (ER-beta), and progesterone receptor (PR) was carried out in prostate needle biopsies obtained before and after radiotherapy from 60 patients with adenocarcinoma.
|
15900599 |
2005 |
Adenocarcinoma
|
0.400 |
AlteredExpression
|
group |
LHGDN |
Expression of estrogen receptor-beta isoforms in Barrett's metaplasia, dysplasia and esophageal adenocarcinoma.
|
15517897 |
2004 |
Adenocarcinoma
|
0.400 |
AlteredExpression
|
group |
LHGDN |
[Evaluation of wild-type estrogen receptor beta and its isoforms: ER-beta/delta 5/6 i ER-beta/delta 6 in endometrial adenocarcinoma].
|
14674142 |
2003 |
Adenocarcinoma
|
0.400 |
AlteredExpression
|
group |
BEFREE |
Recurrent adenocarcinoma revealed markedly decreased levels in 15 of 40 cases and was ERbeta negative in five recurrent lesions.
|
12497580 |
2003 |
Adenocarcinoma
|
0.400 |
AlteredExpression
|
group |
LHGDN |
Recurrent adenocarcinoma revealed markedly decreased levels in 15 of 40 cases and was ERbeta negative in five recurrent lesions.
|
12497580 |
2003 |
Adenocarcinoma
|
0.400 |
AlteredExpression
|
group |
LHGDN |
Estrogen receptor beta is expressed in human stomach adenocarcinoma.
|
12073050 |
2002 |
Adenocarcinoma
|
0.400 |
AlteredExpression
|
group |
LHGDN |
It is concluded that all adenocarcinomas of the esophagus and most precursor lesions, Barrett's Metaplasia (BM) with or without dysplasia, express ER-B in a significantly high percentage of the cells.
|
12168823 |
2002 |